San Carlos, CA, United States of America

Mark S Dennis

This inventor holds 101 USPTO granted patents and 83 published patent applications, plus 6 CIPO patents and 42 EPO patents, primarily in Antibody Engineering (CPC class C07K2317-92). Top assignees: Genentech, Inc., Denali Therapeutics Inc., Washington University. Active years: 1985-2026.

USPTO Granted Patents = 101 (Patent Applications = 83)

% Patents Active = 86.1

CIPO Patents = 6 (Patent Applications = 24)

EPO Patents = 42 (Patent Applications = 70)

Average Co-Inventor Count = 3.8

ph-index = 20

Forward Citations = 1,097(Granted Patents)

Forward Citations (Not Self Cited) = 988(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

San Bruno, CA (US) (1985)
Sán Carlos, CA (US) (2014)
San Carlos, CA (US) (1998 - 2024)
South San Francisco, CA (US) (2014 - 2024)

Company Filing History:

Denali Therapeutics Inc.

patents

3 out of 1,376

Washington University

where one patent can have more than one assignee

Years Active: 1985-2026

Loading Chart...

Areas of Expertise:

Anti-CD3 Antibodies

Anti-HER2 Antibodies

Transferrin Receptor

Immunoconjugates

Anti-ApoE Antibodies

Tumor Treatment

Polypeptides

Antibody Compositions

Anti-CLL-1 Antibodies

Blood-Brain Barrier

Anti-TREM2 Antibodies

Anti-BACE1 Antibodies

101 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12583937 - COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR (2026-03-24),

2. 12540175 - ANTI-APOE ANTIBODIES (2026-02-03),

3. 12492263 - Anti-HER2 Antibodies and Immunoconjugates (2025-12-09),

4. 12466896 - ANTI-CD3 ANTIBODIES AND METHODS OF USE (2025-11-11),

5. 12240902 - Anti-TREM2 antibodies and methods of use thereof (2025-03-04),

6. 12162948 - Methods of engineering transferrin receptor binding polypeptides (2024-12-10),

7. 11939396 - Anti-tryptase antibodies, compositions thereof, and uses thereof (2024-03-26),

8. 11926660 - Anti-ApoE antibodies (2024-03-12),

9. 11912778 - Methods of engineering transferrin receptor binding polypeptides (2024-02-27),

10. 11866496 - Humanized anti-CD79B antibodies and immunoconjugates and methods of use (2024-01-09),

11. 11795232 - Engineered transferrin receptor binding polypeptides (2023-10-24),

12. 11773185 - Anti-BACE1 antibodies and methods of use thereof (2023-10-03),

13. 11732054 - Anti-CD3 antibodies and methods of use (2023-08-22),

14. 11612150 - Transferrin receptor transgenic models (2023-03-28),

15. 11530275 - Anti-CD3 antibodies and methods of use (2022-12-20),

Title: The Innovative Journey of Mark S Dennis

Introduction: Mark S Dennis, a talented inventor based in San Carlos, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Mark S Dennis holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Mark S Dennis has worked for renowned tech companies, leading research institutions, and innovative startups. His expertise in developing cutting-edge solutions has earned him a reputation as a visionary in the industry.

Collaborations: Throughout his career, Mark S Dennis has collaborated with top engineers, scientists, and researchers to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking technologies.

Conclusion: Mark S Dennis continues to push the boundaries of innovation, with a relentless drive to create solutions that have a positive impact on society. His passion for technology and commitment to excellence make him a true pioneer in the world of inventions.